238 related articles for article (PubMed ID: 30991141)
1. Upstream signaling events leading to elevated production of pro-survival nitric oxide in photodynamically-challenged glioblastoma cells.
Fahey JM; Korytowski W; Girotti AW
Free Radic Biol Med; 2019 Jun; 137():37-45. PubMed ID: 30991141
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1.
Fahey JM; Stancill JS; Smith BC; Girotti AW
J Biol Chem; 2018 Apr; 293(14):5345-5359. PubMed ID: 29440272
[TBL] [Abstract][Full Text] [Related]
3. Enhanced aggressiveness of bystander cells in an anti-tumor photodynamic therapy model: Role of nitric oxide produced by targeted cells.
Bazak J; Fahey JM; Wawak K; Korytowski W; Girotti AW
Free Radic Biol Med; 2017 Jan; 102():111-121. PubMed ID: 27884704
[TBL] [Abstract][Full Text] [Related]
4. Cytoprotective signaling associated with nitric oxide upregulation in tumor cells subjected to photodynamic therapy-like oxidative stress.
Bhowmick R; Girotti AW
Free Radic Biol Med; 2013 Apr; 57():39-48. PubMed ID: 23261943
[TBL] [Abstract][Full Text] [Related]
5. Negative effects of tumor cell nitric oxide on anti-glioblastoma photodynamic therapy.
Girotti AW; Fahey JM; Korytowski W
J Cancer Metastasis Treat; 2020; 6():. PubMed ID: 33564720
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of pro-tumor nitric oxide by anti-tumor photodynamic therapy.
Girotti AW; Fahey JM
Biochem Pharmacol; 2020 Jun; 176():113750. PubMed ID: 31836386
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-mediated resistance to photodynamic therapy in a human breast tumor xenograft model: Improved outcome with NOS2 inhibitors.
Fahey JM; Girotti AW
Nitric Oxide; 2017 Jan; 62():52-61. PubMed ID: 28007662
[TBL] [Abstract][Full Text] [Related]
8. Antagonistic Effects of Endogenous Nitric Oxide in a Glioblastoma Photodynamic Therapy Model.
Fahey JM; Emmer JV; Korytowski W; Hogg N; Girotti AW
Photochem Photobiol; 2016 Nov; 92(6):842-853. PubMed ID: 27608331
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of nitric oxide in tumor cells as a negative adaptation to photodynamic therapy.
Girotti AW
Lasers Surg Med; 2018 Jul; 50(5):590-598. PubMed ID: 29504635
[TBL] [Abstract][Full Text] [Related]
10. Accelerated migration and invasion of prostate cancer cells after a photodynamic therapy-like challenge: Role of nitric oxide.
Fahey JM; Girotti AW
Nitric Oxide; 2015 Sep; 49():47-55. PubMed ID: 26068242
[TBL] [Abstract][Full Text] [Related]
11. Dual roles of nitric oxide in the regulation of tumor cell response and resistance to photodynamic therapy.
Rapozzi V; Della Pietra E; Bonavida B
Redox Biol; 2015 Dec; 6():311-317. PubMed ID: 26319434
[TBL] [Abstract][Full Text] [Related]
12. The Negative Impact of Cancer Cell Nitric Oxide on Photodynamic Therapy.
Fahey JM; Girotti AW
Methods Mol Biol; 2022; 2451():21-31. PubMed ID: 35505007
[TBL] [Abstract][Full Text] [Related]
13. Regulation of inducible nitric oxide synthase expression by viral A238L-mediated inhibition of p65/RelA acetylation and p300 transactivation.
Granja AG; Sabina P; Salas ML; Fresno M; Revilla Y
J Virol; 2006 Nov; 80(21):10487-96. PubMed ID: 17041221
[TBL] [Abstract][Full Text] [Related]
14. Isoeugenol suppression of inducible nitric oxide synthase expression is mediated by down-regulation of NF-kappaB, ERK1/2, and p38 kinase.
Choi CY; Park KR; Lee JH; Jeon YJ; Liu KH; Oh S; Kim DE; Yea SS
Eur J Pharmacol; 2007 Dec; 576(1-3):151-9. PubMed ID: 17698059
[TBL] [Abstract][Full Text] [Related]
15. Isobutyrylshikonin inhibits lipopolysaccharide-induced nitric oxide and prostaglandin E2 production in BV2 microglial cells by suppressing the PI3K/Akt-mediated nuclear transcription factor-κB pathway.
Jayasooriya RG; Lee KT; Kang CH; Dilshara MG; Lee HJ; Choi YH; Choi IW; Kim GY
Nutr Res; 2014 Dec; 34(12):1111-9. PubMed ID: 25454762
[TBL] [Abstract][Full Text] [Related]
16. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
Giri S; Rattan R; Singh AK; Singh I
J Immunol; 2004 Oct; 173(8):5196-208. PubMed ID: 15470065
[TBL] [Abstract][Full Text] [Related]
17. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB.
Yu Z; Zhang W; Kone BC
Biochem J; 2002 Oct; 367(Pt 1):97-105. PubMed ID: 12057007
[TBL] [Abstract][Full Text] [Related]
18. PI3K-Akt/PKB signaling pathway in neutrophils and mononuclear cells exposed to N-nitrosodimethylamine.
Ratajczak-Wrona W; Jablonska E; Garley M; Jablonski J; Radziwon P; Iwaniuk A; Grubczak K
J Immunotoxicol; 2014; 11(3):231-7. PubMed ID: 23971717
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of cyclooxygenase-2 and inducible nitric oxide synthase by 4-hydroxynonenal in human osteoarthritic chondrocytes through ATF-2/CREB-1 transactivation and concomitant inhibition of NF-kappaB signaling cascade.
Vaillancourt F; Morquette B; Shi Q; Fahmi H; Lavigne P; Di Battista JA; Fernandes JC; Benderdour M
J Cell Biochem; 2007 Apr; 100(5):1217-31. PubMed ID: 17031850
[TBL] [Abstract][Full Text] [Related]
20. Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-kappaB in RAW 264.7 cells.
Oh JH; Lee TJ; Park JW; Kwon TK
Eur J Pharmacol; 2008 Dec; 599(1-3):11-7. PubMed ID: 18838070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
